UKHSA issues new guidance on drug-resistant infections.

On 5 January 2026, the UK Health Security Agency published new infection control guidance for adult social care on multi-drug-resistant organisms (MDROs). These pathogens (e.g. MRSA, VRE, CPE, Candida auris) no longer respond to common antibiotics or antifungals, making infections harder to treat. The guidance gives practical steps for preventing MDRO spread in care settings, such as strict hygiene, appropriate PPE, environmental cleaning, and communication around admissions.

Regulatory/compliance impact: While infection control is always a requirement (Fundamental Standard 12), this guidance specifically addresses the rising threat of MDROs. Providers must review their IPC policies in light of these recommendations. Ignoring it could lead to preventable outbreaks. The guidance also helps meet CQC’s requirements under Regulation 12 (Safe care and treatment) by reinforcing best practice for resistant infections.

Key actions for providers:

- Download and review the full UKHSA MDRO guidance and integrate its key points into your infection control manuals.
- Update staff training to cover MDRO precautions (e.g. hand hygiene before/after all care, enhanced cleaning of touchpoints, screening on admission) as outlined in the guidance.
- Ensure systems for reporting and responding to MDRO detections (from hospitals or labs) are in place so that any carriage is managed with dignity and safety.
- Coordinate with local health partners (NHS trusts, GPs) about clients known to carry MDROs, following the recommendation to communicate MDRO status on transfer.

Implementing the UKHSA advice will bolster resident safety and help providers demonstrate adherence to infection control standards in any CQC inspection.